Tuesday 17 November 2026 Sign in / SubscribeFree daily emailMarket analysisEnterpriseVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Pricing & policy

Organigram receives Nasdaq minimum bid price deficiency notice, with compliance deadline of May 2027

The Canadian cannabis company says its shares closed below US$1.00 for 30 consecutive business days. The notice does not affect trading on Nasdaq or the TSX.

16 Nov 2026 · Organigram Global Inc. OGI · Company news

Organigram Global, a Canadian cannabis company, has disclosed that Nasdaq notified it on 11 November 2026 that it fails the exchange's minimum bid price requirement. Its shares closed below US$1.00 for 30 consecutive business days, which breaches Nasdaq Listing Rule 5450(a)(1).

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on CompePharma and VigiEye
  • One subscription for both sites, cancel any time

Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.

We'll email you a link to confirm your address, then take you to secure checkout (Stripe). Billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. Already a subscriber? Enter your email and the link will sign you in. See our terms and privacy policy.

Company's press release (SEC filing): Organigram Global Inc. ↗

Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.

More Pricing & policyAll →